Front Row Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18K Hold
250
﹤0.01% 522
2025
Q4
$1.27K Hold
250
﹤0.01% 506
2025
Q3
$1.29K Hold
250
﹤0.01% 503
2025
Q2
$1.1K Hold
250
﹤0.01% 495
2025
Q1
$1.53K Hold
250
﹤0.01% 459
2024
Q4
$988 Hold
250
﹤0.01% 464
2024
Q3
$1.48K Hold
250
﹤0.01% 454
2024
Q2
$1.11K Hold
250
﹤0.01% 889
2024
Q1
$1.18K Hold
250
﹤0.01% 874
2023
Q4
$1.26K Hold
250
﹤0.01% 431
2023
Q3
$1.4K Hold
250
﹤0.01% 848
2023
Q2
$2K Hold
250
﹤0.01% 809
2023
Q1
$2K Hold
250
﹤0.01% 825
2022
Q4
$3K Buy
+250
New +$2.91K ﹤0.01% 741

Other funds holding MPT

Front Row Advisors's MPT Position: Q1 2026 in Review

Front Row Advisors held its Medical Properties Trust (MPT) position steady in Q1 2026 at 250 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Front Row Advisors first reported a position in MPT in Q4 2022 and has held it in 14 quarters since. The position peaked at $3K in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Front Row Advisors held 250 shares of Medical Properties Trust worth $1.18K as of Q1 2026.
  • Front Row Advisors left its Medical Properties Trust share count unchanged in Q1 2026.
  • Medical Properties Trust made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #522 holding.
  • Front Row Advisors first reported a position in Medical Properties Trust in Q4 2022 and has held it in 14 quarters since.
  • Front Row Advisors's Medical Properties Trust position peaked at $3K in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.